| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,463 |
8,809 |
$1.28M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,266 |
22,330 |
$905K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,597 |
4,093 |
$659K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,964 |
2,342 |
$509K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,256 |
801 |
$447K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,121 |
1,709 |
$356K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,650 |
8,204 |
$349K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,317 |
815 |
$276K |
| 70450 |
Computed tomography, head or brain; without contrast material |
510 |
424 |
$170K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,031 |
1,871 |
$160K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
518 |
384 |
$148K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,296 |
357 |
$142K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
321 |
233 |
$117K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,301 |
612 |
$115K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
454 |
229 |
$111K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
796 |
510 |
$111K |
| 80053 |
Comprehensive metabolic panel |
7,065 |
5,442 |
$100K |
| 0240U |
|
581 |
486 |
$93K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
590 |
497 |
$71K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
917 |
300 |
$68K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
43 |
40 |
$67K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,364 |
8,864 |
$64K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,268 |
1,935 |
$49K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
738 |
700 |
$43K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
206 |
165 |
$38K |
| 36415 |
Collection of venous blood by venipuncture |
13,719 |
9,879 |
$32K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
944 |
290 |
$30K |
| 99215 |
Prolong outpt/office vis |
696 |
556 |
$29K |
| 80061 |
Lipid panel |
1,554 |
1,367 |
$27K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,614 |
1,409 |
$26K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,784 |
2,122 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
528 |
443 |
$23K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
4,346 |
3,535 |
$23K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
769 |
539 |
$19K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
664 |
582 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,421 |
1,143 |
$17K |
| 97016 |
|
400 |
99 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
395 |
334 |
$16K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
67 |
48 |
$15K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
172 |
88 |
$15K |
| 97162 |
|
337 |
297 |
$15K |
| 84439 |
|
726 |
632 |
$13K |
| 82728 |
|
572 |
492 |
$13K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
100 |
87 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,553 |
2,000 |
$12K |
| 81001 |
|
3,308 |
2,741 |
$12K |
| 82607 |
|
447 |
391 |
$11K |
| 73630 |
|
277 |
229 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,846 |
1,046 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
866 |
676 |
$10K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
206 |
184 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
395 |
334 |
$8K |
| 76830 |
Ultrasound, transvaginal |
58 |
54 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
808 |
645 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
277 |
250 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,754 |
1,190 |
$7K |
| 87077 |
|
588 |
471 |
$7K |
| 83735 |
|
1,616 |
1,044 |
$7K |
| 83540 |
|
511 |
440 |
$6K |
| 74018 |
|
110 |
85 |
$6K |
| 85027 |
|
557 |
476 |
$6K |
| 73610 |
|
90 |
65 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
138 |
128 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
27 |
25 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,508 |
905 |
$4K |
| 73030 |
|
93 |
73 |
$4K |
| 96127 |
|
195 |
164 |
$4K |
| 83550 |
|
432 |
371 |
$4K |
| 87070 |
|
170 |
148 |
$4K |
| 87186 |
|
585 |
471 |
$4K |
| 82570 |
|
380 |
337 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
206 |
184 |
$3K |
| 73564 |
|
22 |
14 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
109 |
90 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
77 |
63 |
$3K |
| 80069 |
|
181 |
153 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
27 |
24 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
56 |
54 |
$3K |
| 80320 |
|
175 |
135 |
$2K |
| 80305 |
|
362 |
288 |
$2K |
| 86803 |
|
68 |
51 |
$2K |
| 97164 |
|
70 |
63 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
369 |
202 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
20 |
13 |
$2K |
| 90836 |
|
91 |
75 |
$2K |
| 85610 |
|
976 |
744 |
$2K |
| 99205 |
Prolong outpt/office vis |
50 |
44 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
231 |
75 |
$2K |
| 83655 |
|
48 |
42 |
$2K |
| 82746 |
|
164 |
143 |
$2K |
| 84484 |
|
1,235 |
845 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
1,112 |
881 |
$2K |
| 97014 |
|
45 |
12 |
$2K |
| 87210 |
|
83 |
65 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
55 |
43 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
277 |
221 |
$2K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
98 |
79 |
$2K |
| 59430 |
|
38 |
31 |
$1K |
| 83690 |
|
838 |
597 |
$1K |
| 85652 |
|
199 |
169 |
$1K |
| 81025 |
|
668 |
482 |
$1K |
| 83970 |
|
60 |
52 |
$1K |
| 84550 |
|
239 |
205 |
$1K |
| 0071A |
|
20 |
19 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
771 |
576 |
$1K |
| 83880 |
|
377 |
292 |
$956.08 |
| 86140 |
|
62 |
51 |
$941.08 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
118 |
97 |
$915.58 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
18 |
17 |
$911.23 |
| 85018 |
|
139 |
96 |
$886.48 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14 |
12 |
$829.67 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
38 |
27 |
$797.67 |
| 85730 |
|
330 |
256 |
$778.25 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
30 |
28 |
$720.42 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
192 |
184 |
$659.37 |
| 99243 |
|
16 |
13 |
$606.20 |
| 87081 |
|
46 |
37 |
$594.13 |
| 99335 |
|
35 |
30 |
$490.32 |
| 72100 |
|
14 |
14 |
$459.16 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
147 |
79 |
$425.23 |
| 80076 |
|
33 |
25 |
$395.93 |
| 73110 |
|
12 |
12 |
$375.94 |
| 0352U |
|
12 |
12 |
$364.80 |
| 84100 |
|
53 |
36 |
$363.45 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
13 |
$325.09 |
| 82248 |
|
26 |
13 |
$321.52 |
| 99336 |
|
85 |
82 |
$321.13 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
332 |
102 |
$256.62 |
| 99442 |
|
13 |
13 |
$244.31 |
| 85379 |
|
333 |
253 |
$209.06 |
| 84703 |
|
160 |
118 |
$191.72 |
| 84156 |
|
45 |
40 |
$176.32 |
| 86038 |
|
16 |
13 |
$171.79 |
| 51798 |
|
40 |
31 |
$168.45 |
| 82043 |
|
15 |
13 |
$167.77 |
| 82150 |
|
15 |
14 |
$166.25 |
| J7050 |
Infusion, normal saline solution, 250 cc |
199 |
105 |
$159.99 |
| 73562 |
|
12 |
12 |
$146.17 |
| 94761 |
|
184 |
151 |
$138.31 |
| 99152 |
|
96 |
67 |
$135.63 |
| 11721 |
|
26 |
24 |
$131.33 |
| 84155 |
|
16 |
12 |
$122.65 |
| 82948 |
|
114 |
53 |
$103.67 |
| 83605 |
|
545 |
376 |
$100.33 |
| 87040 |
|
347 |
168 |
$84.88 |
| 84165 |
|
16 |
12 |
$79.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,245 |
804 |
$78.96 |
| 96376 |
|
74 |
50 |
$74.92 |
| 87205 |
|
14 |
13 |
$63.36 |
| 80329 |
|
14 |
12 |
$60.21 |
| J2704 |
Injection, propofol, 10 mg |
1,730 |
827 |
$58.51 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,740 |
1,081 |
$43.69 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
23 |
16 |
$41.58 |
| 99173 |
|
12 |
12 |
$19.68 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,967 |
1,085 |
$10.99 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
286 |
173 |
$9.94 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
2,749 |
1,776 |
$7.80 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
108 |
61 |
$3.34 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,001 |
624 |
$0.84 |
| 91301 |
|
19 |
16 |
$0.13 |
| 91307 |
|
39 |
33 |
$0.08 |
| G8484 |
Influenza immunization was not administered, reason not given |
13,483 |
10,860 |
$0.00 |
| 4004F |
|
1,593 |
1,367 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
11,248 |
9,050 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,813 |
3,057 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
472 |
342 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
83 |
78 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
12 |
12 |
$0.00 |
| 0502F |
|
19 |
13 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
17 |
13 |
$0.00 |
| 3078F |
|
17 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
12 |
$0.00 |
| 1036F |
|
4,224 |
3,302 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
22 |
13 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
16 |
14 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
764 |
539 |
$0.00 |
| 3017F |
|
365 |
326 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
219 |
197 |
$0.00 |
| A9270 |
Non-covered item or service |
129 |
71 |
$0.00 |
| 3079F |
|
18 |
14 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
40 |
25 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
147 |
129 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
20 |
16 |
$0.00 |